Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Transcat (TRNS) Asset Writedowns and Impairment (2016 - 2022)

Historic Asset Writedowns and Impairment for Transcat (TRNS) over the last 7 years, with Q2 2022 value amounting to $88000.0.

  • Transcat's Asset Writedowns and Impairment fell 6965.52% to $88000.0 in Q2 2022 from the same period last year, while for Jun 2022 it was -$168000.0, marking a year-over-year decrease of 14602.74%. This contributed to the annual value of $34000.0 for FY2022, which is 9465.41% down from last year.
  • Per Transcat's latest filing, its Asset Writedowns and Impairment stood at $88000.0 for Q2 2022, which was down 6965.52% from -$383000.0 recorded in Q1 2022.
  • Over the past 5 years, Transcat's Asset Writedowns and Impairment peaked at $561000.0 during Q2 2020, and registered a low of -$383000.0 during Q1 2022.
  • Moreover, its 4-year median value for Asset Writedowns and Impairment was $99000.0 (2019), whereas its average is $86846.2.
  • Per our database at Business Quant, Transcat's Asset Writedowns and Impairment skyrocketed by 65000.0% in 2021 and then crashed by 50793.65% in 2022.
  • Quarter analysis of 4 years shows Transcat's Asset Writedowns and Impairment stood at $110000.0 in 2019, then skyrocketed by 60.0% to $176000.0 in 2020, then plummeted by 146.59% to -$82000.0 in 2021, then surged by 207.32% to $88000.0 in 2022.
  • Its Asset Writedowns and Impairment was $88000.0 in Q2 2022, compared to -$383000.0 in Q1 2022 and -$82000.0 in Q4 2021.